Kunming, China

Jifeng Luo

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jifeng Luo. Retrieved from https://idiyas.com/inventor/jifeng-luo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jifeng Luo: Innovator in Neurodegenerative Disease Research

Introduction

Jifeng Luo is a prominent inventor based in Kunming, China. He has made significant contributions to the field of neurodegenerative disease research. His work focuses on developing innovative solutions for preventing and treating conditions such as Parkinson's disease.

Latest Patents

Jifeng Luo holds a patent for the use of (5R,7R,10R)-12,15-dioxo-α-selinene in the preparation of drugs. This compound, known as PFC-37, is utilized in the formulation of a drug aimed at preventing and treating neurodegenerative diseases, including Parkinson's disease. His innovative approach highlights the potential of this compound in medical applications.

Career Highlights

Luo is affiliated with the Chinese Academy of Sciences, where he conducts his research. His work has garnered attention for its potential impact on the treatment of neurodegenerative diseases. With a focus on practical applications, he aims to translate his research into effective therapies.

Collaborations

Luo collaborates with fellow researcher Yuehu Wang, contributing to advancements in their shared field of study. Their partnership exemplifies the importance of teamwork in scientific research.

Conclusion

Jifeng Luo's contributions to neurodegenerative disease research through his innovative patent demonstrate his commitment to improving healthcare outcomes. His work continues to inspire advancements in the treatment of challenging medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…